International Patent: BIOMARKER-BASED METABOLIC DYSFUNCTION LIVER DISEASE RISK ANALYSIS SYSTEM AND USE THEREOF

GENEVA, Aug. 14 -- XENOHELIX. CO., LTD. filed a patent application (KR2026/002011) for “BIOMARKER-BASED METABOLIC DYSFUNCTION LIVER DISEASE RISK ANALYSIS SYSTEM AND USE THEREOF”. With publication no. WO/2026/168938, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12Q 1/6883

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....